BZLF1 (190-197) [HUMAN HERPESVIRUS 4]
|
|
Sicherheit
BZLF1 (190-197) [HUMAN HERPESVIRUS 4] Chemische Eigenschaften,Einsatz,Produktion Methoden
BZLF1 (190-197) [HUMAN HERPESVIRUS 4] Upstream-Materialien And Downstream Produkte
Upstream-Materialien
Downstream Produkte
BZLF1 (190-197) [HUMAN HERPESVIRUS 4] Anbieter Lieferant Produzent Hersteller Vertrieb H?ndler.
Global( 7)Lieferanten
Firmenname | Telefon | Land | Produktkatalog | Edge Rate | |
---|---|---|---|---|---|
GL Biochem (Shanghai) Ltd | 21-61263452 13641803416 |
ymbetter@glbiochem.com | China | 9981 | 64 |
Beijing Solarbio Science & Tecnology Co., Ltd. | 010-50973130 4009686088 |
3193328036@qq.com | China | 29764 | 68 |
Nanjing Meihao Pharmaceutical Technology Co., Ltd. | meitaochem@126.com |
meitaochem@126.com | China | 19103 | 58 |
Zhangzhou Sinobioway Peptide Co. Ltd. | 18750546777 |
SINOPEPT@GMAIL.COM | China | 6069 | 58 |
- BZLF1 (190-197) [HUMAN HERPESVIRUS 4]
- CEF15
- EPSTEIN-BARR VIRUS LYTIC CYCLE PROTEIN BZLF-1(190-197)
- H-ARG-ALA-LYS-PHE-LYS-GLN-LEU-LEU-OH
- H2N-RAKFKQLL-OH
- RAKFKQLL
- CEF15, Epstein-Barr Virus Lytic Cycle Protein BZLF-1(190-197)
- peptide